Clinical outcomes of Chinese eyes with irregular corneas managed with a scleral lens
Eye Discovery · 2026
DOI: 10.1016/j.edisc.2026.100043 ↗Kurz gefasst
Fachartikel in der Zeitschrift Eye Discovery, 2026. Verfasst von Qi Tan und 3 weiteren Autor:innen. Die Arbeit nennt 50 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Purpose
To evaluate the clinical outcomes of a four-zone scleral lens for the management of irregular corneas in Chinese patients with primary or secondary corneal ectasias, corneal transplants, or corneal scarring.
Methods
This prospective, multi-site, single-arm, open-label clinical trial enrolled Chinese adults aged 18–65 years (inclusive) with irregular corneas. Participants were fitted with a four-zone scleral lens and attended baseline, lens dispensing, 1-week, 1-month, and 3-month visits. Comprehensive ophthalmic examinations were conducted at baseline and at the 3-month visit and included manifest subjective refraction, best corrected visual acuity (BCVA), anterior segment biomicroscopy, corneal topography, corneal endothelial cell density (ECD), intraocular pressure (IOP), and fundus examination.
Results
A total of 138 participants were enrolled, of whom seven withdrew during the study period. Among the remaining participants, BCVA improved by at least 0.20 logMAR after 1 month of scleral lens wear in 128 participants, corresponding to a success rate of 97.7%, with a median improvement of 0.30 logMAR (range: 0.10 to 1.90 logMAR). On average, 1.5 lenses per eye (standard deviation: 0.6) were required to achieve an optimal fit. No significant adverse events were observed over the 3-month follow-up period. Most participants adhered to a regular lens-wearing regimen, with 72.5% wearing lenses for ≥8 h per day and 83.9% for ≥5 days per week over the 3-month period. A high level of comfort was reported in 90% of eyes.
Conclusions
The four-zone scleral lens demonstrated high effectiveness in improving visual performance in Chinese patients with irregular corneas, with minimal adverse impact on ocular health.
Trial registration
Chinese Clinical Trial Registry number: ChiCTR2200063610. Registered: 13 September 2022; https://www.chictr.org.cn/bin/project/edit?pid=174854 .
Zitieren
APA
Tan, Q., Jiang, J., Cho, P., & Vincent, S. J. (2026). Clinical outcomes of Chinese eyes with irregular corneas managed with a scleral lens. Eye Discovery. https://doi.org/10.1016/j.edisc.2026.100043
Vancouver
Tan Q, Jiang J, Cho P, Vincent SJ. Clinical outcomes of Chinese eyes with irregular corneas managed with a scleral lens. Eye Discovery. 2026. doi:10.1016/j.edisc.2026.100043
BibTeX
@article{Tan2026,
author = {Tan, Qi and Jiang, Jun and Cho, Pauline and Vincent, Stephen J.},
title = {Clinical outcomes of Chinese eyes with irregular corneas managed with a scleral lens},
journal = {Eye Discovery},
year = {2026},
doi = {10.1016/j.edisc.2026.100043}
}
EUVIMED